| Document |
Document Title |
|
WO/2007/101606A1 |
The present invention relates to novel thiosulfonates derivatives. The present invention also provides methods for preventing, treating and/or reducing inflammation-associated diseases in the cardiovascular, connective tissue, pulmonary,...
|
|
WO/2007/087949A2 |
The invention relates to oxonium salts with [(Ro)3O]+ cations and sulfonium salts with [(Ro)3S]+ cations, wherein Ro represents straight-chain or branched alkyl groups with 1-8 C atoms or unsubstituted phenyl or phenyl that is substitute...
|
|
WO/2007/069640A1 |
A radiation-sensitive resin composition which has high transparency to radiation, is excellent in basic properties required of resists, such as sensitivity, resolution, and pattern profile, especially in resolution performance, and is fu...
|
|
WO/2007/061024A1 |
Disclosed is a method for efficiently producing a fluorinated alkylfluorophosphoric acid salt of an aryl sulfonium at low cost without requiring an extremely excessive amount of acid. Specifically disclosed is a method for producing a su...
|
|
WO/2007/046442A1 |
A compound that exhibits high absorption in the long wavelength region of 365 nm or greater and exhibits high sensitivity in the long wavelength region of 365 nm or greater, excelling in solubility in organic solvents; an acid generator ...
|
|
WO/2007/006387A2 |
The invention relates to a method for producing onium-alkylsulfonates by reacting an onium halogenide or carboxylate with a symmetrically substituted dialkyl sulphite or with a asymmetrically substituted dialkyl sulphite at temperatures ...
|
|
WO/2007/007175A2 |
The present application relates to a compound of formula A-X-B, where (i) A-X-B form an ionic compound Ai Xi Bi where Ai and Bi are each individually an organic onium cation; and Xi is anion of the formula Q-R500-SO3 - or (ii) A-X-B form...
|
|
WO/2007/003507A1 |
Compounds of the formula (I), (II), (III), (IV) and wherein, R is hydrogen, C1-C20alkyl; C2-C20alkyl interrupted by one or more O; is -L-X-R2 or - L-R2; R1 has ofr example one of the meanings as given for R; R2 is a monovalent sensitizer...
|
|
WO/2006/134489A1 |
The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) derivatives of sulindac, for the treatment/prevention, alone or in combination, of cancer.
|
|
WO/2006/133330A1 |
Hydrofluoroalkanesulfonates of the general formula R-O-CXH-CX2-SO3M, where R is selected from the group consisting of alkyl groups, functionalized alkyl groups, and alkenyl groups; X is selected from the group consisting of hydrogen and ...
|
|
WO/2006/122773A1 |
The present invention relates to pentafluorosulphanyl-substituted compounds, processes for preparing them, medicaments comprising these compounds, and the use of these compounds for producing medicaments.
|
|
WO/2006/121096A1 |
Disclosed is a radiation-sensitive resin composition which is highly transparent to radiation while being excellent in basic physical properties of a resist such as sensitivity, resolution and pattern shape. This radiation-sensitive resi...
|
|
WO/2006/099974A1 |
Abstract This invention relates to pyrimidine derivatives of general formula (I) in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-recepto...
|
|
WO/2006/072401A1 |
The invention relates to the use of Y terminal groups, where Y represents CF3O- or F5S-, as hydrophobic terminal groups in surface-active compounds. The invention also relates to corresponding novel compounds and to a production method f...
|
|
WO/2006/032462A1 |
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts and all stereoisomers and tautomeric forms of the compounds of formula I can be used as agrochemical active ingredients ...
|
|
WO/2006/029532A1 |
Nitrate esters and methods for mitigating neurodegeneration, affecting neuroprotection, affecting cognition enhancement, and/or preventing or mitigating tissue and/or cellular damage in a subject are described. Neurological or cognitive ...
|
|
WO/2006/027130A1 |
The invention relates to pentafluorosulfanylphenyl-substituted benzoylguanidines, to a method for the production thereof, to their use as a medicament or diagnostic agent, and to a medicament containing these compounds. These pentafluoro...
|
|
WO/2006/027129A1 |
The invention relates to pentafluorosulfanyl benzenes of formula (I) in which R1 to R5 have the meanings as cited in the claims, which depict valuable intermediates, e.g. for producing medicaments, diagnostic agents, liquid crystals, pes...
|
|
WO/2006/019354A1 |
The present invention relates to fixed charge reagents and kits for use in tandem mass spectrometry methods involving multiplex analysis. The compounds of the invention are phenacylamide compounds. The invention also relates to methods f...
|
|
WO/2006/008250A2 |
The invention pertain to novel photoacid generator compounds of the formula (I, II or III), Wherein R1 is for example C1-C18alkylsulfonyl or phenylsulfonyl, phenyl-C1-C3alkylsulfonyl, , naphthylsulfonyl, anthracylsulfonyl or phenanthryls...
|
|
WO/2006/006616A1 |
A method of evaluating the evenness of suplatast tosilate crystals; and stable crystals having evenness in optical purity. The method of evaluating the evenness of suplatast tosilate crystals is characterized by comprising (a) a step in ...
|
|
WO/2005/123878A1 |
The invention relates to a liquid crystal medium compounds of formula (I) and to a liquid crystal medium based on a mixture of polar compounds. The invention is characterised in that said mixture contains one or more compounds of formula...
|
|
WO/2005/121894A2 |
The present invention relates to novel photoacid generators having the formula (I) wherein the residues have the meanings indicated in the description.
|
|
WO/2005/116038A1 |
[PBOBLEMS] To provide a polymerization initiator having excellent ability to initiate a cationic polymerization, which does not contain arsenic or antimony. [MEANS FOR SOLVING PROBLEMS] An onium salt or a transition metal complex salt of...
|
|
WO/2005/109102A1 |
Disclosed are a novel (meth)acrylic monomer having the function of a photoacid generator, a photosensitive polymer prepared with the monomer, and a chemically amplified photoresist composition including the polymer. The monomer have a me...
|
|
WO/2005/102985A1 |
A method is described for the preparation of polymorphic forms of water-soluble derivatives of probucol compounds having the following formula (II); where R1, R2, R3, R4, R5, R6, Z and Z’ are defined herein.
|
|
WO/2005/095335A1 |
The invention aims at providing ylide compounds represented by the general formula (1) and being useful as herbicide and a process for the production thereof, as well as at providing a process for the preparation of halomethyl ketones kn...
|
|
WO/2005/062847A2 |
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
|
|
WO/2005/063018A1 |
Present invention relates to a haloalkene compound of the formula (I)or its salt: wherein each of X1 and X2 is halogen; Y is alkyl, haloalkyl or phenyl; n is 0 to 5; L is -C(=B)Q, -C(=B)B’Q, -C(=B)N(D)Q, -N(D)Q, -N(D)C(=B)Q, -N(D)C(=B)...
|
|
WO/2005/058808A1 |
The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a N-substituted-...
|
|
WO/2005/051902A2 |
The invention relates to the field of drug delivery, in particular to compounds and methods for the chemical modification of a proteinaceous channel to be used in pharmaceutical delivery vehicles for controlled and/ or localised release ...
|
|
WO/2005/047239A1 |
The invention relates to pentafluorosulfanyl benzoylguanidines of formula (I), in which R1 to R4 are defined as cited in the claims. Said substances are suitable for use as anti-arrhythmic medicaments comprising cardio-protective compone...
|
|
WO/2005/047240A1 |
The invention relates to pentafluoride-sulfanyl-benzenes of formula (I), wherein groups from R1 to R5 correspond to meanings given in claims and constitute valuable intermediates, for example for producing drugs, diagnosis agents, liquid...
|
|
WO/2005/047242A2 |
The present invention provides thiosulphate compounds having the formulae R-S-SO3¯, R-S-SO3H, R-L-S-SO3, R-L-S-SO3H, X-L-S-SO3¯and X-L-S-SO3H, where R is a reporter group, a carrier molecule or a solid support, L is a linker and X is a...
|
|
WO/2005/047241A1 |
The invention relates to a method for producing 4-pentafluoride-sulfanyl-benzoylguanidines of formula (I) wherein groups from R1 to R4 correspond to meanings given in claims. The compounds of the formula (I) constitute NHE1 inhibitors an...
|
|
WO/2005/044789A1 |
The present invention is drawn to the manufacture of higher hydrocarbons from methane via mathanesulfonic acid, sulfene, and other pathways.
|
|
WO/2005/037778A1 |
A process by which a triarylsulfonium salt in which only one aromatic ring differs from the others can be efficiently produced. The process, which is for producing a triarylsulfonium salt represented by the general formula [4]: (wherein ...
|
|
WO/2005/034885A1 |
Compositions are provided that include a photoinitiator system for free radical polymerization reactions. More specifically, the photoinitiator includes an arylsulfinate ion and a triarylsulfonium ion. Polymerization methods are also pro...
|
|
WO/2005/027157A2 |
A salt fusible at ordinary temperature which comprises: a cation ingredient obtained by introducing a cationic group into a volatile organic solvent; and an anion ingredient selected from the group consisting of an inorganic ion, sulfoni...
|
|
WO/2005/021484A2 |
The invention relates to a method for producing ionic liquids and ionic solids which takes recourse to a novel, especially modular production process. According to the inventive method, those salts from an ionic carbonate, hydrocarbonate...
|
|
WO/2005/021492A1 |
The invention relates to pentafluorosulfanyl phenyl-substituted benzoylguanidines of formulas I and II, wherein R1, R1', R2, R2', R3, R3', R4 and X are defined as cited in the claims. Said compounds are suitable for use as anti-arrhythmi...
|
|
WO/2005/009927A2 |
Acetyl anhydrides such as acetyl sulfate are produced by a process for comprising contacting methane and carbon dioxide in an anhydrous environment in the presence of effective amounts of a transition metal catalyst and a reaction promot...
|
|
WO/2005/000243A2 |
A pharmaceutical composition, comprising: a compound of formula (1) in polymorphic crystalline Form A: (1) together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic Fo...
|
|
WO/2005/000801A1 |
A monosulfonium salt bearing one sulfonio group in the molecule and having a purity of 96 % or above is produced without purification with a decrease in the amount of residual unreacted reactants. An aryl compound (a), a sulfoxide compou...
|
|
WO/2004/113277A2 |
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-+ related disease.
|
|
WO/2004/113281A1 |
The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivativ...
|
|
WO/2004/113275A2 |
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.
|
|
WO/2004/101490A2 |
The present invention relates to a novel photoactive compounds that can be used in formulating photoresist compositions.
|
|
WO/2004/093799A2 |
Thyroid receptor ligands are provided which have the general formula (I), wherein: R1 is formula (II); R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl of 3 to 5 carbons, provided that ...
|
|
WO/2004/089925A1 |
The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
|
